Delineation of human peptide transporter 1 (hPepT1)-mediated uptake and transport of substrates with varying transporter affinities utilizing stably transfected hPepT1/Madin-Darby canine kidney clones and Caco-2 cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 314, Issue 3, 2005, Pages 1093-1100

  Bhardwaj, Rajinder K ^a   Herrera Ruiz, Dea ^b   Sinko, Patrick J ^a   Gudmundsson, Olafur S ^c   Knipp, Gregory ^a  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PENICILLIN G; PEPTIDE TRANSPORTER 1; SODIUM; VALACICLOVIR;

ARTICLE; CELL CLONING; CELL CULTURE; CELL LINE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; DRUG TRANSPORT; ENZYME SUBSTRATE COMPLEX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MEASUREMENT; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SCREENING; TIME; TRANSPORT KINETICS;

ACYCLOVIR; AMINOLEVULINIC ACID; ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CADHERINS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROGEN-ION CONCENTRATION; PENICILLIN G; SODIUM; TRANSFECTION; VALINE;

EID: 23944470195     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.105.087148     Document Type: Article

References (43)

1. Amidon GL and Sadee W (1999) Membrane Transporters As Drug Targets. Kluwer Academic/Plenum Publishers, New York.
2. Artursson P (1991) Cell cultures as models for drug absorption across the intestinal mucosa. Crit Rev Ther Drug Carrier Syst 8:305-330.
3. Balimane P and Sinko P (2000) Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells. Biopharm Drug Dispos 21:165-174.
4. Balimane PV, Tamai I, Guo A, Nakanishi T, Kitada H, Leibach FH, Tsuji A, and Sinko PJ (1998) Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem Biophys Res Commun 250:246-251.
5. Behrens I, Kamm W, Dantzig AH, and Kissel T (2004) Variation of peptide transporter (PepT1 and HPT1) expression in Caco-2 cells as a function of cell origin. J Pharm Sci 93:1743-1754.
6. Bohets H, Annaert P, Mannens G, Van Beijsterveldt L, Anciaux K, Verboven P, Meuldermans W, and Lavrijsen K (2001) Strategies for absorption screening in drug discovery and development. Curr Top Med Chem 1:367-383.
7. Burckhardt BC, Lorenz J, Burckhardt G, and Steffgen J (2004) Interactions of benzylpenicillin and non-steroidal anti-inflammatory drugs with the sodium-dependent dicarboxylate transporter NaDC-3. Cell Physiol Biochem 14:415-424.
8. Busch AE, Schuster A, Waldegger S, Wagner CA, Zempel G, Broer S, Biber J, Murer H, and Lang F (1996) Expression of a renal type I sodium/phosphate transporter (NaPi-1) induces a conductance in Xenopus oocytes permeable for organic and inorganic anions. Proc Natl Acad Sci USA 93:5347-5351.
9. Cook TJ, Jiansheng Y, and Sinko PJ (1997) Involvement of the organic cation and oligopeptide carrier proteins in the apical transporter of vacyclovir across Caco-2 cell monolayers. Pharm Res (NY) 14 (Suppl):S-20.
10. Doring F, Walter J, Will J, Focking M, Boll M, Amasheh S, Clauss W, and Daniel H (1998) Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications. J Clin Investig 101:2761-2767.
11. Freeman TC, Bentsen BS, Thwaites DT, and Simmons NL (1995) H+/di-tripeptide transporter (PepT1) expression in the rabbit intestine. Pflugers Arch 430:394-400.
12. Gres MC, Julian B, Bourrie M, Meunier V, Roques C, Berger M, Boulenc X, Berger Y, and Fabre G (1998) Correlation between oral drug absorption in humans and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm Res (NY) 15:726-733.
13. Guo A, Hu P, Balimane PV, Leibach FH, and Sinko PJ (1999) Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line. J Pharmacol Exp Ther 289:448-454.
14. Han HK, Rhie JK, Oh DM, Saito G, Hsu CP, Stewart BH, and Amidon GL (1999) CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs. J Pharm Sci 88:347-350.
15. Hatanaka T, Haramura M, Fei YJ, Miyauchi S, Bridges CC, Ganapathy PS, Smith SB, Ganapathy V, and Ganapathy ME (2004) Transport of amino acid-based prodrugs by the Na+- and Cl(-)-coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery. J Pharmacol Exp Ther 308:1138-1147.
16. Herrera-Ruiz D, Faria TN, Bhardwaj R, Timoszyk J, Gudmundsson OS, Moench P, Wall DA, Smith RL, and Knipp GT (2004) A novel hPepT1-stably transfected cell line: establishing a correlation between expression and function. Mol Pharm 1:136-144.
17. Herrera-Ruiz D and Knipp GT (2003) Current perspectives on established and putative mammalian oligopeptide transporters. J Pharm Sci 92:691-714.
18. Hilgendorf C, Spahn-Langguth H, Regardh CG, Lipka E, Amidon GL, and Langguth P (2000) Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. J Pharm Sci 89:63-75.
19. Hillgren KM, Kato A, and Borchardt RT (1995) In vitro systems for studying intestinal drug absorption. Med Res Rev 15:83-109.
20. Hsu CP, Walter E, Merkle HP, Rothen-Rutishauser B, Wunderli-Allenspach H, Hilfinger JM, and Amidon GL (1999) Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells. AAPS PharmSci 1:E12.
21. Hu M (1993) Comparison of uptake characteristics of thymidine and zidovudine in a human intestinal epithelial model system. J Pharm Sci 82:829-833.
22. Irie M, Terada T, Sawada K, Saito H, and Inui K (2001) Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells. J Pharmacol Exp Ther 298:711-717.
23. Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, and Grove JR (1999) MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J Pharm Sci 88:28-33.
24. Kikuchi R, Kusuhara H, Sugiyama D, and Sugiyama Y (2003) Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier. J Pharmacol Exp Ther 306:51-58.
25. Knipp GT, Ho NF, Barsuhn CL, and Borchardt RT (1997) Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. J Pharm Sci 86:1105-1110.
26. Langer S, Abels C, Botzlar A, Pahernik S, Rick K, Szeimies RM, and Goetz AE (1999) Active and higher intracellular uptake of 5-aminolevulinic acid in tumors may be inhibited by glycine. J Investig Dermatol 112:723-728.
27. Leibach FH and Ganapathy V (1996) Peptide transporters in the intestine and the kidney. Annu Rev Nutr 16:99-119.
28. Liang R, Fei YJ, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL, Hediger MA, Ganapathy V, and Leibach FH (1995) Human intestinal H+/peptide cotransporter. Cloning, functional expression and chromosomal localization. J Biol Chem 270:6456-6463.
29. Liu W, Liang R, Ramamoorthy S, Fei YJ, Ganapathy ME, Hediger MA, Ganapathy V, and Leibach FH (1995) Molecular cloning of PEPT 2, a new member of the H+/peptide cotransporter family, from human kidney. Biochim Biophys Acta 1235:461-466.
30. Mahraoui L, Rodolosse A, Barbat A, Dussaulx E, Zweibaum A, Rousset M, and Brot-Laroche E (1994) Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochem J 298:629-633.
31. McLoughlin JL and Cantrill RC (1984) The effect of δ-aminolevulinic acid on the high affinity uptake of aspartic acid by rat brain synaptosomes. Gen Pharmacol 15:553-555.
32. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, and Willingham MC (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85:4486-4490.
33. Poschet JF, Hammond SM, and Fairclough PD (1996) Characterisation of penicillin-G uptake in rabbit small-intestinal brush-border membrane vesicles. Biochim Biophys Acta 1278:233-240.
34. Rud E, Gederaas O, Hogset A, and Berg K (2000) 5-Aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters. Photochem Photobiol 71:640-647.
35. Sawada K, Terada T, Saito H, Hashimoto Y, and Inui KI (1999) Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2. J Pharmacol Exp Ther 291:705-709.
36. Skowronski MT, Ishikawa Y, and Ishida H (2000) Enhancement by epinephrine of benzylpenicillin transport in rat small intestine. J Pharmacol Exp Ther 293:128-135.
37. Sinko PJ and Balimane PV (1998) Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats. Biopharm Drug Dispos 19:209-217.
38. Smith C, Klein A, and Zimmerman T (1993) Influx of valacyclovir into cynomolgus monkey intestinal brush border membranes is transporter mediated and enhanced over acyclovir, in 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 1993 Oct 17-20; New Orleans, LA. Abstract 1750, American Society for Microbiology, Washington, DC.
39. Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, and Endou H (2002) Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 300:918-924.
40. Tamai I, Nakanishi T, Hayashi K, Terao T, Sai Y, Shiraga T, Miyamoto K, Takeda E, Higashida H, and Tsuji A (1997) The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine. J Pharm Pharmacol 49:796-801.
41. Tavelin S, Milovic V, Ocklind G, Olsson S, and Artursson P (1999) A conditionally immortalized epithelial cell line for studies of intestinal drug transport. J Pharmacol Exp Ther 290:1212-1221.
42. von Bonsdorff CH, Fuller SD, and Simons K (1985) Apical and basolateral endocytosis in Madin-Darby canine kidney (MDCK) cells grown on nitrocellulose filters. EMBO (Eur Mol Biol Organ) J 4:2781-2792.
43. Zhang EY, Knipp GT, Ekins S, and Swaan PW (2002) Structural biology and function of solute transporters: implications for identifying and designing substrates. Drug Metab Rev 34:709-750.